Drug Profile
ODM 106
Alternative Names: ODM-106Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Orion
- Class
- Mechanism of Action GABA B receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Essential tremor
Most Recent Events
- 27 Jan 2016 Discontinued - Phase-I for Essential tremor (In volunteers) in Germany (PO) (Orion pipeline, January 2016)
- 01 Jan 2015 Preclinical trials in Essential tremor in Finland (PO) before January 2015